Moderna's cod vaccine

EMA COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE ISSUES

eAwaz Medicine

CAMBRIDGE – Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending a variation to the marketing authorization (CMA) to include a 25 µg two-dose series of Spikevax (mRNA-1273) for active immunization to prevent coronavirus disease 2019 …

Moderna Spikevax

CHMP RECOMMENDS MODERNA COVID-19 BOOSTER IN ADOLESCENTS 

eAwaz Medicine

CAMBRIDGE – Moderna, Inc, (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending a variation to the conditional marketing authorization (CMA) to include a booster dose of Spikevax, the Company’s COVID-19 vaccine, at the 50 µg …

Modernas mRNA 1273.214

MODERNA’S BIVALENT BOOSTER MRNA-1273.214 IS EFFECTIVE AGAINST OMICRON

eAwaz Medicine

CAMBRIDGE – Moderna, Inc. has announced new clinical data on its bivalent (Omicron) COVID booster candidate, mRNA-1273.214. One month after administration in previously vaccinated and boosted participants, a 50 µg booster dose of mRNA-1273.214 elicited potent neutralizing antibody responses against the Omicron subvariants BA.4 and BA.5 in all participants regardless of prior infection. Based on this and prior data, the …

Moderna Chief Executive Stephane Bancel

Moderna announces clinical trial data of its bivalent vaccine

eAwaz Medicine

Washington – US Biotechnology company Moderna has announced new clinical data on its bivalent COVID-19 booster platform including data on the Company’s first bivalent booster candidate, mRNA-1273.211. Stéphane Bancel, Chief Executive Officer of Moderna, said: “The results validate our bivalent strategy, which we announced and began pursuing in February 2021. The results indicate that mRNA-1273.211 at the 50-µg dose level induced …